ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,326, issued on Oct. 27, was assigned to INSTITUTE OF SCIENCE TOKYO (Tokyo).

"Agent for preventing or treating frontotemporal lobar degeneration" was invented by Hitoshi Okazawa (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide an agent for preventing or treating frontotemporal lobar degeneration which does not cause noticeable adverse reactions and exhibits an excellent effect of preventing and treating frontotemporal lobar degeneration caused by different factors. In the present invention, a human monoclonal antibody that specifically binds to human HMGB1, which comprises heavy chain CDR1, heavy ...